RENBP and early-onset autosomal dominant Alzheimer disease: The relevance of this in Alzheimer’s disease progression is by the reduction of Aβ and amyloid γ (Aγ) protein precursor stability and ultimately the decrease of Aβ and Aγ production that results from the reduced β and γ-secretase activities and increased α-secretase activity [13].